Stay updated on Atogepant Safety Extension in Chronic Migraine Clinical Trial

Sign up to get notified when there's something new on the Atogepant Safety Extension in Chronic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atogepant Safety Extension in Chronic Migraine Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new study-record version dated 2026-10-15 was added, covering study status and multiple results sections, including participant flow, baseline characteristics, outcome measures, and adverse events. The record notes that quality control review has not concluded and that it was returned on 2026-11-04.
    Difference
    0.6%
    Check dated 2026-11-08T04:46:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the website as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T01:46:30.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-25T01:44:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The study record now indicates that results have been submitted, replacing the previous status that no results were posted.
    Difference
    0.1%
    Check dated 2026-10-18T01:32:38.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:56:56.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study record history now shows a new revision tag, v3.7.0, replacing the previous v3.6.6. This reflects an update to the page's underlying system version rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-20T01:06:39.000Z thumbnail image

Stay in the know with updates to Atogepant Safety Extension in Chronic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atogepant Safety Extension in Chronic Migraine Clinical Trial page.